SKI Market

Indian Indices

Sensex

84,233.64 -40.28
( -0.05%)

Global Indices

Nasdaq

50,215.24 58.36
(0.12%)

Dow Jones

6,964.30 -21.52
(-0.31%)

Hang Seng

57,678.97 1,315.03
(2.33%)

Nikkei 225

10,491.19 137.35
(1.33%)

Forex

USD-INR

90.66 0.22
(0.24%)

EUR-INR

107.64 0.80
(0.75%)

GBP-INR

123.65 0.62
(0.51%)

JPY-INR

0.58 0.00
(0.85%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Beryl Drugs Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524606

INE415H01017

18.6259045

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

47.13

EPS(TTM)

Face Value()

Div & Yield %

0.46

Back

nlc india ltd

India Cements reports consolidated net profit of Rs 8.81 crore in the September 2025 quarter

Oct 18,2025

Net profit of India Cements reported to Rs 8.81 crore in the quarter ended September 2025 as against net loss of Rs 339.12 crore during the previous quarter ended September 2024. Sales rose 9.32% to Rs 1117.04 crore in the quarter ended September 2025 as against Rs 1021.84 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	1117.04	1021.84	9
OPM %	7.26	-15.93	-
PBDT	84.86	-77.11	LP
PBT	10.39	-132.23	LP
NP	8.81	-339.12	LP

84,233.64 -40.28 ( -0.05%)

50,215.24 58.36 (0.12%)

6,964.30 -21.52 (-0.31%)

57,678.97 1,315.03 (2.33%)

10,491.19 137.35 (1.33%)

90.66 0.22 (0.24%)

107.64 0.80 (0.75%)

123.65 0.62 (0.51%)

0.58 0.00 (0.85%)